# Vedanta Biosciences

**Canonical:** https://apis.io/providers/vedanta-biosciences/  
**Website:** https://www.vedantabio.com/  
**APIs profiled:** 0

Vedanta Biosciences is a late clinical-stage biopharmaceutical company headquartered at 19 Blackstone Street in Cambridge, Massachusetts, founded by PureTech Health together with a group of scientific co-founders who pioneered the modern understanding of cross-talk between the human microbiome and the immune system. The company develops a potential new category of oral Live Biotherapeutic Products built from rationally defined consortia of human commensal bacteria grown from pure clonal cell banks rather than donor-derived stool, and it maintains technical expertise in the manufacture of live organisms. Its lead program, VE303, is an eight-strain defined bacterial consortium in the global Phase 3 RESTORATiVE303 registrational study for the prevention of recurrent Clostridioides difficile infection, following Phase 2 results showing a greater than 80% reduction in the odds of CDI recurrence versus placebo; VE202 is in development for inflammatory bowel disease and VE707 for prevention of multidrug-resistant organism infections. Vedanta has raised a $68 million Series D and a $106.5 million financing, and its programs are supported by non-dilutive awards from BARDA and CARB-X. Vedanta is a therapeutics developer, not a software vendor: it runs a WordPress marketing and corporate site, publishes no developer portal, no SDKs, no GitHub organization and no machine-readable API contract, and an August 2026 probe of vedantabio.com found no OpenAPI, no /llms.txt, no MCP endpoint, no A2A agent card and an empty /.well-known/ discovery surface.

## Kin Score — 11.3 / 100 (emerging)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (-0.7 from 12.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 23.8 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Vedanta Biosciences Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Biotechnology, Life Sciences, Pharmaceuticals, Microbiome, Live Biotherapeutic Products, Immunology, Gastroenterology, Infectious Disease, Clinical Research, Drug Development, Healthcare, United States

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/vedanta-biosciences/). Scores are computed from the provider's own public artifacts under a published rubric.